Drugs / autologous transduced TILs
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00091104 | Jul 2004 → Aug 2010 | cutaneous melanoma | National Institutes of Health Clinical Center (CC) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous transduced TILs | “Patients then receive autologous transduced TILs IV over 20-30 minutes on day 0.” NCT00091104 ↗ |
| Modality | Cell therapy | “autologous transduced TILs” NCT00091104 ↗ |
| Route | Intravenous | “autologous transduced TILs IV over 20-30 minutes” NCT00091104 ↗ |